PACT Pharma raises $75m to develop neoTCR-T cell therapies for solid tumors
PACT Pharma, a California-based clinical stage company, which is focused on developing fully personalized neoTCR-T cell therapies for solid tumors, has raised $75 million in ... Read More
MiraDx to enroll patients for non-tumor based microRNA clinical trial
MicroRNA clinical trial : MiraDx, a Los Angeles-based molecular genetics company, has initiated patient enrollment in collaboration with UCLA for the non-tumor based microRNA biomarker-driven ... Read More
Carmell Therapeutics gets IND clearance for CT-101 bone healing accelerant
Carmell Therapeutics has secured clearance from the US Food and Drug Administration (FDA) for its investigational new drug application (IND) for CT-101, its first product, ... Read More
ATAI Life Sciences partners with Neuronasal to develop concussion treatment
ATAI Life Sciences, a German biotech company focused on developing drugs for mental illnesses, has partnered with Neuronasal to develop a short-term treatment for mild ... Read More
Chinese pharma company CF PharmTech raises $90m for respiratory drugs
Chinese pharma company CF PharmTech has secured a $90 million Series E investment led by New Alliance Capital for accelerating the global development of respiratory ... Read More
ForaCare Suisse launches FOR A 6 GTel diabetes monitoring device
ForaCare Suisse has launched a new cellular multi-functional diabetes monitoring device FORA 6 GTel based on its Lab in the Pocket technology. The Lab in ... Read More
Biotricity completes development of Biopatch ECG patch platform
Biotricity said that it has wrapped up development of Biopatch, a new ECG patch platform for cardiac patients with fewer complications. The US medical technology ... Read More
Impulse Dynamics raises $80m to commercialize Optimizer Smart System
Impulse Dynamics, a US medical device company, has secured $80.25 million in a Series D financing round led by medical technology investor Amzak Health Investors ... Read More
Baxter to acquire Seprafilm Adhesion Barrier from Sanofi for $350m
Baxter International, a US-based health care company, has signed a deal worth $350 million to acquire Seprafilm Adhesion Barrier and related assets from French pharma ... Read More
LIAISON QFT-Plus automated screening solution gets FDA nod for TB detection
Qiagen and DiaSorin have secured approval from the US Food and Drug Administration (FDA) to use QuantiFERON-TB Plus (QFT-Plus automated screening solution) on the latter’s ... Read More